Cardio Diagnostics Holdings, Inc. (Cardio Diagnostics) has announced an upcoming annual meeting of stockholders scheduled for November 15, 2024. The meeting will be entirely virtual, allowing stockholders to attend, vote, and submit questions during the live webcast. The Notice of Annual Meeting of Stockholders and Proxy Statement details the admission process and the business to be conducted, which includes the election of seven board nominees, approval of a reverse stock split, approval of future issuance of shares, and ratification of the company's independent registered public accounting firm for the fiscal year ended December 31, 2023. Stockholders are encouraged to vote promptly, with options to vote by proxy card or via the Internet. The meeting's agenda also addresses a proposal for the future...Show More

Cardio Diagnostics Holdings, Inc. (Cardio Diagnostics) has announced an upcoming annual meeting of stockholders scheduled for November 15, 2024. The meeting will be entirely virtual, allowing stockholders to attend, vote, and submit questions during the live webcast. The Notice of Annual Meeting of Stockholders and Proxy Statement details the admission process and the business to be conducted, which includes the election of seven board nominees, approval of a reverse stock split, approval of future issuance of shares, and ratification of the company's independent registered public accounting firm for the fiscal year ended December 31, 2023. Stockholders are encouraged to vote promptly, with options to vote by proxy card or via the Internet. The meeting's agenda also addresses a proposal for the future issuance of shares equal to 20% or more of the outstanding common stock in a non-public transaction, subject to Nasdaq Marketplace Listing Rule 5635(d). Additionally, the ratification of Prager Metis CPA's LLC as the company's auditor for the upcoming fiscal year is proposed. The event emphasizes the importance of stockholder participation in the decision-making process of the company.